Controlling treatment allocation bias in a registry analysis when comparing calcineurin inhibitors☆
To access this article, please choose from the options below
☆ This work was supported in part through a grant (SKT) from the National Institute of Diabetes, Digestive and Kidney Diseases DK54928-055.
PII: S0041-1345(03)00875-3
doi:10.1016/j.transproceed.2003.08.011
© 2003 Elsevier Science Inc. All rights reserved.
